Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.430
+0.030 (2.14%)
At close: Sep 2, 2026, 4:00 PM EDT
1.400
-0.030 (-2.09%)
After-hours: Sep 2, 2026, 7:23 PM EDT
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $7.54 million as of September 2, 2026. Its market cap has increased by 2.93% in one year.
Market Cap
7.54M
Enterprise Value
-3.12M
1-Year Change
2.93%
Ranking
Category
Stock Price
$1.43
ChartMarket Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $7.54M, a decrease of -86.84%. That is a compound annual growth rate of -32.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 7.54M | 28.89% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Soligenix | 8.27M |
| Bolt Biotherapeutics | 7.67M |
| Alzamend Neuro | 7.67M |
| Ensysce Biosciences | 7.64M |
| Evogene | 7.51M |
| Ernexa Therapeutics | 7.46M |
| Creative Medical Technology Holdings | 7.45M |
| Skye Bioscience | 7.44M |